← Leaderboards
Adrian J Wolstenholme
University Of Georgia
$2,147,761
Attributed
$2,147,761
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $600K · FY2012–18$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,147,761 · 5
By mechanism
R01$1,122,709 · 1
R21$1,020,052 · 3
R13$5,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionParasitesNematodaPharmaceutical PreparationsAnthelminticsIvermectinIn VivoPathway InteractionsParasitic NematodeAffectReportingProgramsCellsAdultDrug DiscoveryTropical DiseaseBrugia MalayiNeglectGenesDrug UsageDoseFilarial ElephantiasesLeadDrug Resistance
Grant awards (9)
Screening C. elegans mutant strains for new clues about ivermectin and its mode of action$187,500
R21 · FY2018 · AI · contact PI
Trafficking of parasitic nematode ion channels$187,500
R21 · FY2017 · AI · contact PI
The antifilarial activity of ivermectin and diethylcarbamizine$375,000
R01 · FY2016 · AI · contact PI
Trafficking of parasitic nematode ion channels$225,000
R21 · FY2016 · AI · contact PI
The antifilarial activity of ivermectin and diethylcarbamizine$375,000
R01 · FY2015 · AI · contact PI
The antifilarial activity of ivermectin and diethylcarbamizine$372,709
R01 · FY2014 · AI · contact PI
Anthelmintics: From discovery of new drugs to modes of action and resistance$5,000
R13 · FY2014 · AI · contact PI
Can drug targets from parasitic nematodes be usefully expressed in C. elegans?$185,427
R21 · FY2013 · AI · contact PI
Can drug targets from parasitic nematodes be usefully expressed in C. elegans?$234,625
R21 · FY2012 · AI · contact PI